Nolato AB (FRA:NBF)
€ 4.34 -0.060 (-1.36%) Market Cap: 1.19 Bil Enterprise Value: 1.28 Bil PE Ratio: 18.27 PB Ratio: 2.31 GF Score: 72/100

Q3 2025 Nolato AB Earnings Call Transcript

Oct 28, 2025 / 01:45PM GMT
Release Date Price: €5.53 (-0.09%)

Key Points

Positve
  • Nolato AB (STU:NBF) reported a 20% increase in operating profit, reaching SEK281 million, driven by strong margin improvements.
  • The company achieved a 2% organic growth in both its business areas, Medical Solutions and Engineered Solutions, when adjusted for currency.
  • Nolato AB (STU:NBF) maintained a strong financial position with a debt ratio of 0.6 times EBITDA, allowing for potential expansion and acquisitions.
  • The Medical Solutions segment saw a significant margin improvement of 1.4 percentage points, ending at 12.1% for the quarter.
  • The company is actively expanding its operations in Hungary, Poland, and Malaysia, with ongoing projects progressing according to plan.
Negative
  • The Engineered Solutions segment experienced a slight decline in the materials business year-on-year, attributed to pressures in the automotive sector.
  • Cash flow after investments was lower than the previous year, at SEK180 million compared to SEK191 million.
  • The company's US operations in the Medical Solutions segment still have room for margin improvement compared to other regions.
  • The Chinese facility for consumer electronics is not yet fully utilized, indicating potential underperformance in capacity utilization.
  • The IVD segment has experienced volatility and back-and-forth in delivered volumes, despite being seen as a long-term growth opportunity.
Operator

Hello, everyone, and welcome to today's presentation with Nolato. With us presenting today, we have the CEO, Christer Wahlquist; and CFO, Per-Ola Holmstrom. (Operator Instructions)

And with that said, please go ahead with your presentation.

Christer Wahlquist
Nolato AB - President, Chief Executive Officer

Good afternoon, and welcome to the presentation of Nolato's Third Quarter 2025. This is Christer Wahlquist speaking. During the quarter, we saw organic growth in both our two business areas, approximately 2% if we adjust for currency. And that, in combination with the strong increase of our margins created a strong increase of our EBITDA. So the sales ended up at SEK2.3 billion on some and the operating profit rose 20% to SEK281 million, that includes a nonrecurring item of SEK7 million corresponding to an insurance claim.

But as I mentioned, we saw strong improvement of margins in both business areas. We have maintained a very strong financial position with a debt ratio 0.6 times EBITDA, giving us opportunity and possibility to expand

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot